Related references
Note: Only part of the references are listed.LRRK2 and neurodegeneration
Gabriel Santpere et al.
ACTA NEUROPATHOLOGICA (2009)
LRRK2 G2385R Modulates Age at Onset in Parkinson's Disease: A Multi-Center Pooled Analysis
E. K. Tan et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS (2009)
Leucine-Rich Repeat Kinase 2 (LRRK2): A Key Player in the Pathogenesis of Parkinson's Disease
Payal N. Gandhi et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2009)
Case control analysis of LRRK2 Gly2385Arg in Alzheimer's disease
E. K. Tan et al.
NEUROBIOLOGY OF AGING (2009)
LRRK2 G2019S and R1441G mutations associated with Parkinson's disease are common in the Basque Country, but relative prevalence is determined by ethnicity
A. Gorostidi et al.
NEUROGENETICS (2009)
Ashkenazi Parkinson's disease patients with the LRRK2 G2019S mutation share a common founder dating from the second to fifth centuries
Anat Bar-Shira et al.
NEUROGENETICS (2009)
Lrrk2 R1441G-related Parkinson's disease: evidence of a common founding event in the seventh century in Northern Spain
Ignacio F. Mata et al.
NEUROGENETICS (2009)
Haplotype analysis of Lrrk2 R1441H carriers with parkinsonism
Owen A. Ross et al.
PARKINSONISM & RELATED DISORDERS (2009)
Analysis of Lrrk2 R1628P as a risk factor for Parkinson's disease
Owen A. Ross et al.
ANNALS OF NEUROLOGY (2008)
Lrrk2 R1628P in Non-Chinese Asian Races
Eng-King Tan et al.
ANNALS OF NEUROLOGY (2008)
Uniting Chinese across Asia: The LRRK2 Gly2385Arg risk variant
E. K. Tan et al.
EUROPEAN JOURNAL OF NEUROLOGY (2008)
LRRK2 R1628P increases risk of Parkinson's disease: replication evidence
E. K. Tan et al.
HUMAN GENETICS (2008)
Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study
Daniel G. Healy et al.
LANCET NEUROLOGY (2008)
Myocardial 123Metaiodobenzylguanidine uptake in genetic Parkinson's disease
Aldo Quattrone et al.
MOVEMENT DISORDERS (2008)
The LRRK2 Arg1628Pro variant is a risk factor for Parkinson's disease in the Chinese population
Chin-Song Lu et al.
NEUROGENETICS (2008)
Lrrk2 R1441C parkinsonism is clinically similar to sporadic Parkinson disease
K. Haugarvoll et al.
NEUROLOGY (2008)
Hyposmia in G2019S LRRK2-related parkinsonism - Clinical and pathologic data
L. Silveira-Moriyama et al.
NEUROLOGY (2008)
Progression of dopaminergic dysfunction in a LRRK2 kindred A multitracer PET study
R. Nandhagopal et al.
NEUROLOGY (2008)
A founding LRRK2 haplotype shared by Tunisian, US, European and Middle Eastern families with Parkinson's disease
L. Warren et al.
PARKINSONISM & RELATED DISORDERS (2008)
The role of common genetic risk variants in Parkinson disease
E-K Tan
CLINICAL GENETICS (2007)
LRRK2 phosphorylates moesin at threonine-558: characterization of how Parkinson's disease mutants affect kinase activity
Mahaboobi Jaleel et al.
BIOCHEMICAL JOURNAL (2007)
Pathogenic mutations in Parkinson disease
Eng-King Tan et al.
HUMAN MUTATION (2007)
Transcranial ultrasound in different monogenetic subtypes of Parkinson's disease
Katherine J. Schweitzer et al.
JOURNAL OF NEUROLOGY (2007)
Comparing LRRK2 Gly2385Arg carriers with noncarriers
Eng-King Tan et al.
MOVEMENT DISORDERS (2007)
Comparing knowledge and attitudes towards genetic testing in Parkinson's disease in an American and Asian population
Eng-King Tan et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2007)
Lrrk2 G2385R is an ancestral risk factor for Parkinson's disease in Asia
Matthew J. Farrer et al.
PARKINSONISM & RELATED DISORDERS (2007)
LRRK2 G2019S founder haplotype in the Chinese population
Eng-King Tan et al.
MOVEMENT DISORDERS (2007)
The LRRK2 Gly2385Arg variant is associated with Parkinson's disease: genetic and functional evidence
E. K. Tan et al.
HUMAN GENETICS (2007)
Parkinson's disease due to the R1441G mutation in Dardarin:: A founder effect in the Basques
Javier Simon-Sanchez et al.
MOVEMENT DISORDERS (2006)
LRRK2 G2019S in families with Parkinson disease who originated from Europe and the Middle East:: Evidence of two distinct founding events beginning two millennia ago
Cyrus P. Zabetian et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2006)
Identification and haplotype analysis of LRRK2 G2019S in Japanese patients with Parkinson disease
C. P. Zabetian et al.
NEUROLOGY (2006)
Kinase activity is required for the toxic effects of mutant LRRK2/dardarin
Elisa Greggio et al.
NEUROBIOLOGY OF DISEASE (2006)
A common missense variant in the LRRK2 gene, Gly2385Arg, associated with Parkinson's disease risk in Taiwan
Alessio Di Fonzo et al.
NEUROGENETICS (2006)
LRRK2 G2019S as a cause of Parkinson's disease in North African Arabs
S Lesage et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
LRRK2 G2019S as a cause of Parkinson's disease in Ashkenazi Jews
LJ Ozelius et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Genetic testing in Parkinson disease - Promises and pitfalls
Eng-King Tan et al.
ARCHIVES OF NEUROLOGY (2006)
Common variants of LRRK2 are not associated with sporadic Parkinson's disease
S Biskup et al.
ANNALS OF NEUROLOGY (2005)
Comprehensive evaluation of common genetic variation within LRRK2 reveals evidence for association with sporadic Parkinson's disease
L Skipper et al.
HUMAN MOLECULAR GENETICS (2005)
Lrrk2 pathogenic substitutions in Parkinson's disease
IF Mata et al.
NEUROGENETICS (2005)
PET in LRRK2 mutations: comparison to sporadic Parkinson's disease and evidence for presymptomatic compensation
JR Adams et al.
BRAIN (2005)
LRRK2 gene in Parkinson disease -: Mutation analysis and case control association study
C Paisán-Ruíz et al.
NEUROLOGY (2005)
A clinic-based study of the LRRK2 gene in Parkinson disease yields new mutations
CP Zabetian et al.
NEUROLOGY (2005)
The G2019S LRRK2 mutation is uncommon in an Asian cohort of Parkinson's disease patients
EK Tan et al.
NEUROSCIENCE LETTERS (2005)
LRRK2 haplotype analyses in European and North African families with Parkinson disease:: A common founder for the G2019S mutation dating from the 13th century
S Lesage et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2005)
LRRK2 R1441G in Spanish patients with Parkinson's disease
IF Mata et al.
NEUROSCIENCE LETTERS (2005)
The LRRK2 I2012T, G2019S, and I2020T mutations are rare in Taiwanese patients with sporadic Parkinson's disease
CS Lu et al.
PARKINSONISM & RELATED DISORDERS (2005)
Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease
C Paisán-Ruíz et al.
NEURON (2004)
Mutations in LRRK2 cause autosomal-dominant Parkinsonism with pleomorphic pathology
A Zimprich et al.
NEURON (2004)
A new locus for Parkinson's disease (PARK8) maps to chromosome 12p11.2-q13.1
M Funayama et al.
ANNALS OF NEUROLOGY (2002)
Variability and validity of polymorphism association studies in Parkinson's disease
EK Tan et al.
NEUROLOGY (2000)
Share Paper
